Your browser doesn't support javascript.
loading
Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers.
Zhong, Jie; Sun, Zijian; Li, Sheng; Yang, Liu; Cao, Yuepeng; Bao, Jun.
Affiliation
  • Zhong J; Department of Medical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Sun Z; Department of Medical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Li S; Department of Medical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Yang L; Department of Colorectal Surgery, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Cao Y; Department of Colorectal Surgery, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Bao J; Department of Medical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China. baojun@jszlyy.com.cn.
Discov Oncol ; 14(1): 94, 2023 Jun 11.
Article in En | MEDLINE | ID: mdl-37302081
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Discov Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Discov Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: